This ticker symbol is under the radar, which Cathie Wood is purchasing over the last 3 months without a single sell. During the last week, she bought daily.
Recently FDA approved their drug
> Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for ICLUSIG® (ponatinib) for adult patients with chronic-phase (CP) chronic myeloid leukemia (CML) with resistance or intolerance to at least two prior kinase inhibitors. The updated label includes an optimized, response-based ICLUSIG dosing regimen in CP-CML with a daily starting dose of 45 mg and, upon achieving ≤1% BCR-ABL1IS, dose reduction to 15 mg. This dosing regimen aims to maximize benefit-risk by providing efficacy and decreasing the risk of adverse events (AEs), including arterial occlusive events (AOEs).
There is another post yesterday on this from u/EuroSStore
The effect of the news is not realized yet on the stock price. I see an easy gain here. It has a Buy rating from Schwab Equity Rating International®.
Note: I own shares in the company, and I am following this stock for a few months.
Disclaimer: This information is only for educational purposes. Do not make any investment decisions based on the information in this article. Do you own due diligence or consult your financial professional before making any investment decision.